Riordan J R, Deuchars K, Kartner N, Alon N, Trent J, Ling V
Nature. 1985;316(6031):817-9. doi: 10.1038/316817a0.
The multidrug-resistance phenotype expressed in mammalian cell lines is complex. Cells selected with a single agent can acquire cross-resistance to a remarkably wide range of compounds which have no obvious structural or functional similarities. The basis for cross-resistance seems to be a decreased net cellular accumulation of the drug involved, and has been attributed to alterations in the plasma membrane. An over-expressed plasma membrane glycoprotein of relative molecular mass (Mr) 170,000 (P-glycoprotein) is consistently found in different multidrug-resistant human and animal cell lines, and in transplantable tumours. Consequently, it has been postulated that P-glycoprotein directly or indirectly mediates multidrug resistance. Here we report the cloning of a complementary DNA encoding P-glycoprotein. Southern blot analysis of hamster, mouse and human DNA using this cDNA as a probe showed that P-glycoprotein is conserved and is probably encoded by a gene family, and that members of this putative family are amplified in multidrug-resistant cells.
哺乳动物细胞系中表达的多药耐药表型很复杂。用单一药物筛选出的细胞可获得对范围广泛的化合物的交叉耐药性,这些化合物并无明显的结构或功能相似性。交叉耐药的基础似乎是相关药物在细胞内的净积累减少,这被归因于质膜的改变。在不同的多药耐药人类和动物细胞系以及可移植肿瘤中,始终能发现一种相对分子质量(Mr)为170,000的质膜糖蛋白(P-糖蛋白)过度表达。因此,有人推测P-糖蛋白直接或间接介导多药耐药。在此,我们报告了编码P-糖蛋白的互补DNA的克隆。用该cDNA作为探针,对仓鼠、小鼠和人类DNA进行的Southern印迹分析表明,P-糖蛋白是保守的,可能由一个基因家族编码,并且该假定家族的成员在多药耐药细胞中发生了扩增。